dChan
Anonymous ID: 5031c8 March 19, 2020, 7:59 p.m. No.8483631   🗄️.is 🔗kun   >>3648 >>3668 >>3951 >>4017 >>4145

>>8483601

>https://twitter.com/Breaking911/status/1240834216646119426

 

URGENT: Los Angeles Mayor says he will ‘deputize’ city officials to ‘drive around’ & enforce the “stay at home” order, implying there will be arrests if citizens don’t comply

 

“People are getting guns. They’re going crazy…”

 

“We’ll pay ‘em a visit…”

Anonymous ID: 5031c8 March 19, 2020, 8:20 p.m. No.8483894   🗄️.is 🔗kun   >>3940 >>3983

https://www.cnbc.com/2020/03/19/what-is-chloroquine-trump-and-elon-musk-have-touted-for-coronavirus.html

 

Here’s why Trump and Elon Musk see potential in a drug called chloroquine to treat coronavirus

 

When Dr. Mike Pellini, a physician and biotech investor, read the news about the spread of a virus that caused pneumonia-like symptoms, he decided to keep on hand a supply of an anti-malarial drug called chloroquine.

 

Pellini, who tweeted about the decision to his followers in early February, was early to this thinking. A month later, Tesla CEO Elon Musk sparked massive interest in the drug after tweeting that chloroquine was “maybe worth considering” as a potential treatment for the COVID-19 coronavirus.

 

On Thursday, the White House took notice.

 

President Donald Trump said he had directed the Food and Drug Administration to investigate whether chloroquine, which is available by prescription only, should be given to patients with the virus. Bayer, the international drugmaker, then noted in a press release that it would donate 3 million tablets of the drug Resochin, or chloroquine phosphate, to U.S. patients. Trump also pointed to another existing drug, remdesivir, an anti-viral developed by drugmaker Gilead, which is already being used in China to treat COVID-19.

 

Neither drug is currently approved by the FDA to treat the coronavirus. So it is important “not to provide false hope,” FDA Commissioner Stephen Hahn said at the White House’s daily press briefing. But Trump has “asked us to be aggressive” and “break through exciting, lifesaving treatment, and we’re doing that at the FDA,” he added.